Effectiveness of Premedication with Pronase and Semithicone for Visualization the Mucosa during the Endoscopy: An Endoscopist-blinded, prospective, Randomized Study

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IPR-16008913

Enrollment

Unknown

Registered

2016-07-26

Start date

2016-08-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

early cancer of the upper digestive tract

Interventions

Group A:pronase and simethicone

Group B:Lidocaine hydrochloride mucilage

Eligibility

Sex/Gender

All

Age

15 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Aged between 15 and 80 years; (2) Take gastroscopy in the endoscopy center of Friendship Hospital.

Exclusion criteria

Exclusion criteria: (1) Have contraindication of gastroscopy; (2) Allergic to the medicine of the trail; (3) Have digestive diseases which threat to life; (4) Have active blood in the digestive tract; (5) Undergo surgery of upper digestive tract; (6) Pregnancy or nursing mothers; (7) Do not want to participant in this trail.

Design outcomes

Primary

Measure	Time frame
pathological results;Small lesions;	—

Secondary

Measure	Time frame
score of gastric body;score of fundus;score of antrum;number of the position need flushing;quantity of water;time of gasroscopy;	—

Countries

China

Contacts

Public ContactZHANG Shutian

Beijing Friendship Hospital

zhangstccmu@sina.cn+86 13911021992

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026